Achieving sustainable healthcare through deprescribing-Reference-Cited by-同舟云学术

Achieving sustainable healthcare through deprescribing

Published:2022-10-04 Issue:10 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Gnjidic Danijela¹,Johansson Minna²,Meng Dina Muscat³,Farrell Barbara⁴,Langford Aili¹,Reeve Emily⁵

Affiliation:

1. School of Pharmacy, Faculty of Medicine and Health; The University of Sydney; NSW Australia

2. Cochrane Sustainable Healthcare; Cochrane Sweden, Cochrane

3. Cochrane Sustainable Healthcare; Cochrane Sweden and Cochrane Denmark, Cochrane

4. Bruyere Research Institute, Ottawa and Department of Family Medicine; University of Ottawa; Ottawa Canada

5. Clinical and Health Sciences; University of South Australia; SA Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference11 articles.

1. UK Department of Health & Social Care Good for you, good for us, good for everybody: a plan to reduce overprescribing to make patient care better and safer, support the NHS, and reduce carbon emissions 2021 https://www.gov.uk/government/publications/national-overprescribing-review-report

2. Reducing inappropriate polypharmacy: the process of deprescribing;Scott;JAMA Internal Medicine,2015

3. Withdrawal of antihypertensive drugs in older people;Reeve;Cochrane Database of Systematic Reviews,2020

4. Rapid versus slow withdrawal of antiepileptic drugs;Ayuga Loro;Cochrane Database of Systematic Reviews,2022

5. Interventions for the reduction of prescribed opioid use in chronic non-cancer pain;Eccleston;Cochrane Database of Systematic Reviews,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cost of potentially inappropriate medications for older adults in Canada: A comparative cross‐sectional study;Journal of the American Geriatrics Society;2024-09-05

2. Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks;Expert Review of Clinical Pharmacology;2024-05-20

3. Arzneimitteltherapie von arterieller Hypertonie und Vorhofflimmern bei gebrechlichen Patienten;Die Innere Medizin;2024-03-08

4. Strategies for Identifying Patients for Deprescribing of Blood Pressure Medications in Routine Practice: An Evidence Review;Current Hypertension Reports;2024-02-02

5. Polypharmacy and Deprescribing in Older Adults;Annual Review of Medicine;2024-01-29